Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mikart Compliant with DSCSA Mandates | Contract Pharma

What are you searching for?

Sign in
Breaking News

Mikart Compliant with DSCSA Mandates

Partnered with Optel Vision and TraceLink to fully comply with 2017 through 2023 mandates

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Mikart Inc., a contract development and manufacturing organization, is fully compliant with 2017 through 2023 Drug Supply Chain Security Act (DSCSA) mandates for serialization and aggregation.
 
According to Blair Jones, vice president of sales and marketing, Mikart has already successfully “run serialization from bottle to pallet” for millions of tablets since September 2015.
 
The Atlanta based company has partnered with Optel Vision, which makes the hardware and software that generates, reads, applies and verifies codes throughout the entire packaging process, and TraceLink, the data warehouse that makes all the information contained in the serialization codes available to every point in the pharmaceutical supply chain.
 
“Applying identifying codes to all levels of packaging really plays an important role in countering the growing problem of drug counterfeiting and in ensuring consumer safety,” said Mr. Jones.
 
Mikart offers services including pharmaceutical development, clinical trial manufacturing and packaging, regulatory submissions, commercial scale manufacturing, and packaging.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics